Feasibility of establishing PVC in the Ugandan health system
By Juliet & MartinSeptember 2004
Why monitor drugs
To document unknown Adverse Drug Reactions (ADR) and maximize safety
To encourage health professionals to share concerns about drugs – create an awareness of safety issues & drugs
What should be monitored?
All drugs, but priority to be given to ARVs, anti malarials, TB drugs.
Which reports to be investigated?
All suspected ADR but with special emphasis on unexpected ADRs and those that significantly affect compliance
Who monitors?
Health workers and care givers
The PV teams and MTC
How should monitoring occur?
patients
NPVC
HW
RPVC
monitoring
Monitoring
monitoring
monitoringRegular reports
Less regular
When to encourage reporting events or reactions
2 weeks to one month
How to manage non serious events
Sensitization of patients and health workers on frequent occurrences that may affect compliance
Resources available
HR can be mobilized
Financial resources are limited and needs mobilizing
Critical success factors
Adequate financial resources
Good communication
A good infrastructure (labs, equipment etc)
Well trained and sensitized health workers
Good will by all parties